Cargando…
Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures
BACKGROUND AND AIM: Cardiovascular diseases (CVDs) are globally the leading cause of death and hypertension is a significant risk factor. Treatment with glucagon-like peptide-1 (GLP-1) receptor agonists has been associated with decreases in blood pressure and CVD risk. Our aim was to investigate the...
Autores principales: | Lundgren, Julie R., Færch, Kristine, Witte, Daniel R., Jonsson, Anna E., Pedersen, Oluf, Hansen, Torben, Lauritzen, Torsten, Holst, Jens J., Vistisen, Dorte, Jørgensen, Marit E., Torekov, Signe S., Johansen, Nanna B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778378/ https://www.ncbi.nlm.nih.gov/pubmed/31586493 http://dx.doi.org/10.1186/s12933-019-0937-7 |
Ejemplares similares
-
Habitual physical activity is associated with lower fasting and greater glucose-induced GLP-1 response in men
por: Janus, Charlotte, et al.
Publicado: (2019) -
Role of fasting duration and weekday in incretin and glucose regulation
por: Clemmensen, Kim K B, et al.
Publicado: (2020) -
Role of fasting duration and weekday in incretin and glucose regulation
por: Clemmensen, Kim K B, et al.
Publicado: (2021) -
Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test
por: Jonsson, Anna, et al.
Publicado: (2021) -
Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses
por: Engelbrechtsen, Line, et al.
Publicado: (2018)